Holders — by stockHoldings — by fund
FCPM III SERVICES B.V.
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0002013410
$750.4M
disclosed book value
11
positions
38.3%
largest position share
Positions, as of 2026-06-30
top 11 of 11 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | NEWAMSTERDAM PHARMA COMPANY | 8.5M | $287.7M | 38.3% |
| 2 | MPLTMAPLIGHT THERAPEUTICS INC | 3.2M | $115.6M | 15.4% |
| 3 | DYNDYNE THERAPEUTICS INC | 3.8M | $85.5M | 11.4% |
| 4 | VORVOR BIOPHARMA INC | 4.1M | $75.8M | 10.1% |
| 5 | DAMORA THERAPEUTICS INC | 2.4M | $63.5M | 8.5% |
| 6 | REPLREPLIMUNE GROUP INC | 2.8M | $31.1M | 4.1% |
| 7 | CRESCENT BIOPHARMA INC. | 1.7M | $30.2M | 4% |
| 8 | AURAAURA BIOSCIENCES INC | 4.1M | $28.8M | 3.8% |
| 9 | ENGENE HOLDINGS INC | 9.6M | $16.7M | 2.2% |
| 10 | BCYCBICYCLE THERAPEUTICS PLC | 3.5M | $14.7M | 2% |
| 11 | ENGENE HOLDINGS INC | 2.9M | $834,376 | 0.1% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.